![Hiroshi Nagashima](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hiroshi Nagashima
Hoofd Techniek/Wetenschap/O&O bij PorMedTec Co., Ltd.
Profiel
Hiroshi Nagashima has worked as a Representative Director & Chief Scientist at PorMedTec Co., Ltd.
since 2020.
Actieve functies van Hiroshi Nagashima
Bedrijven | Functie | Begin |
---|---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
PorMedTec Co., Ltd.
![]() PorMedTec Co., Ltd. BiotechnologyHealth Technology PorMedTec Co., Ltd. is a Japanese company that specializes in the development of medical pigs for organ transplantation and regenerative medicine. The company was founded in 2017 by Genjiro Miwa and is based in Kawasaki, Japan. PorMedTec aims to provide solutions to the overwhelming lack of organ donors by using pigs for organ transplantation and regenerative organs. The company develops and uses high-value pigs developed for medical purposes and supplies products inexpensively and stably. PorMedTec also offers technical services such as custom-made gene modification pigs and cloning pigs as models for developing drugs and treatments. | Health Technology |